Page last updated: 2024-11-02

pd 98059 and HIV

pd 98059 has been researched along with HIV in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oshima, T1
Flores, SC1
Vaitaitis, G1
Coe, LL1
Joh, T1
Park, JH1
Zhu, Y1
Alexander, B1
Alexander, JS1

Other Studies

1 other study available for pd 98059 and HIV

ArticleYear
HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways.
    AIDS (London, England), 2000, Mar-31, Volume: 14, Issue:5

    Topics: Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme

2000